Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Magnesium L-glutamate Tetrahydrate
2. 18543-68-5
3. Magnesium (s)-4-amino-4-carboxybutanoate Tetrahydrate
4. L-glutamic Acid Hemimagnesium Salt Tetrahydrate, >=98.0% (nt)
Molecular Weight | 388.61 g/mol |
---|---|
Molecular Formula | C10H24MgN2O12 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 10 |
Exact Mass | 388.1179659 g/mol |
Monoisotopic Mass | 388.1179659 g/mol |
Topological Polar Surface Area | 211 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 329 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 7 |
ABOUT THIS PAGE
65
PharmaCompass offers a list of Magnesium L-Glutamate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Magnesium L-Glutamate manufacturer or Magnesium L-Glutamate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Magnesium L-Glutamate manufacturer or Magnesium L-Glutamate supplier.
PharmaCompass also assists you with knowing the Magnesium L-Glutamate API Price utilized in the formulation of products. Magnesium L-Glutamate API Price is not always fixed or binding as the Magnesium L-Glutamate Price is obtained through a variety of data sources. The Magnesium L-Glutamate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Magnesium L-Glutamate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Magnesium L-Glutamate, including repackagers and relabelers. The FDA regulates Magnesium L-Glutamate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Magnesium L-Glutamate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Magnesium L-Glutamate supplier is an individual or a company that provides Magnesium L-Glutamate active pharmaceutical ingredient (API) or Magnesium L-Glutamate finished formulations upon request. The Magnesium L-Glutamate suppliers may include Magnesium L-Glutamate API manufacturers, exporters, distributors and traders.
Magnesium L-Glutamate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Magnesium L-Glutamate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Magnesium L-Glutamate GMP manufacturer or Magnesium L-Glutamate GMP API supplier for your needs.
A Magnesium L-Glutamate CoA (Certificate of Analysis) is a formal document that attests to Magnesium L-Glutamate's compliance with Magnesium L-Glutamate specifications and serves as a tool for batch-level quality control.
Magnesium L-Glutamate CoA mostly includes findings from lab analyses of a specific batch. For each Magnesium L-Glutamate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Magnesium L-Glutamate may be tested according to a variety of international standards, such as European Pharmacopoeia (Magnesium L-Glutamate EP), Magnesium L-Glutamate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Magnesium L-Glutamate USP).